Antisoma Plans to List its Shares in the United States
04 avr. 2005 02h16 HE
|
Antisoma plc
LONDON, April 4, 2005 (PRIMEZONE) -- Cancer drug developer Antisoma plc (LSE:ASM) announces today that it intends to list its shares on NASDAQ. As an interim step, the Company will establish a Level...
Antisoma and Raylo Sign Major Manufacturing Deal for AS1411
14 mars 2005 02h10 HE
|
Antisoma plc
LONDON and EDMONTON, Alberta, Canada, March 14, 2005 (PRIMEZONE) -- Cancer drug developer Antisoma plc (LSE:ASM) announces that it has signed an agreement with Raylo Chemicals of Edmonton, Alberta,...
Antisoma to Present at SG Cowen Conference on March 17
10 mars 2005 08h16 HE
|
Antisoma plc
LONDON, March 10, 2005 (PRIMEZONE) -- Antisoma plc (LSE: ASM) today announces that Chief Executive Officer, Glyn Edwards, will be presenting at the 25th SG Cowen Annual Healthcare conference, Boston,...
Antisoma plc reports H1 results
16 févr. 2005 02h26 HE
|
Antisoma plc
LONDON, Feb. 16, 2005 (PRIMEZONE) -- Cancer drug developer Antisoma plc (LSE:ASM) today announces its interim results for the period ended 31 December 2004.
Highlights
- Acquisition of U.S....
Antisoma completes acquisition of Aptamera
04 févr. 2005 03h11 HE
|
Antisoma plc
LOUISVILLE, Ken. and LONDON, Feb. 4, 2005 (PRIMEZONE) -- Further to the announcement made yesterday, Antisoma plc (LSE:ASM) announces the completion of its acquisition of Aptamera Inc. This follows...
Aptamera's Shareholders Approve Acquisition by Antisoma
03 févr. 2005 02h12 HE
|
Antisoma plc
LONDON and LOUISVILLE, Ken., Feb. 3, 2005 (PRIMEZONE) -- Cancer drug developer Antisoma plc (LSE:ASM) announces that the shareholders of Aptamera Inc yesterday approved Antisoma's acquisition of...
Acquisition: UK cancer specialist Antisoma to acquire U.S. cancer company Aptamera
10 janv. 2005 02h10 HE
|
Antisoma plc
LOUISVILLE, Ken. and LONDON, Jan. 10, 2005 (PRIMEZONE) -- Acquisition will add promising clinical product AGRO100 to Antisoma's pipeline
Cancer drug development company Antisoma plc (LSE:ASM)...
Antisoma AGM Update
23 nov. 2004 02h24 HE
|
Antisoma plc
LONDON, Nov. 23, 2004 (PRIMEZONE) -- Speaking at today's Annual General Meeting of Antisoma plc (LSE:ASM), Chairman Dr. Barry Price will review progress in the Company's pipeline of cancer drugs and...
Antisoma Telomere Targeting Agent Stops Tumour Growth In Prostate Cancer Model
04 nov. 2004 02h12 HE
|
Antisoma plc
LONDON, Nov. 4, 2004 (PRIMEZONE) -- Cancer drug developer Antisoma today presents new data showing that one of its telomere targeting agents (TTAs) rapidly blocks prostate tumour growth in a human...
New lymphoma data support Antisoma's plans for AS1406
06 oct. 2004 02h10 HE
|
Antisoma plc
LONDON, Oct. 6, 2004 (PRIMEZONE) -- Cancer drug development company Antisoma plc (LSE:ASM) will today present further promising data for its targeted apoptosis drug AS1406. Speaking at the Human...